AGMO
| Gene Symbol | AGMO |
|---|---|
| Entrez Gene | 392636 |
| Alt Symbol | TMEM195 |
| Species | Human |
| Gene Type | protein-coding |
| Description | alkylglycerol monooxygenase |
| Other Description | glyceryl-ether monooxygenase|transmembrane protein 195 |
| Swissprots | Q6ZNB7 A6NCH5 A4D114 |
| Accessions | EAL24290 EAL24291 EAW93665 Q6ZNB7 AK131284 BAD18458 BC108676 AAI08677 KJ534765 AHW56405 XM_006715730 XP_006715793 XM_006715731 XP_006715794 XM_011515402 XP_011513704 XM_011515403 XP_011513705 NM_001004320 NP_001004320 |
| Function | Glyceryl-ether monooxygenase that cleaves the O-alkyl bond of ether lipids. Ether lipids are essential components of brain membranes. {ECO:0000269|PubMed:20643956}. |
| Subcellular Location | Endoplasmic reticulum membrane {ECO:0000269|PubMed:20643956}; Multi-pass membrane protein {ECO:0000269|PubMed:20643956}. |
AGMO / TMEM195 Antibody Blocking Peptide - LS-E16336 from LifeSpan Bioscience
|
||||||||||
AGMO / TMEM195 Antibody Blocking Peptide - LS-E16334 from LifeSpan Bioscience
|
||||||||||
AGMO / TMEM195 Antibody Blocking Peptide - LS-E16335 from LifeSpan Bioscience
|
||||||||||
TMEM195-Antibody-N-term-Blocking-peptide - BP13099a from Abgent, a WuXi AppTec company
|
||||||||||
FLJ16237 Protein Lysate (APL11006) - APL11006 from Aviva Systems Biology
|
||||||||||
TMEM195 Blocking Peptide - 33R-6155 from Fitzgerald
|
||||||||||
TMEM195 Blocking Peptide - 33R-1200 from Fitzgerald
|
||||||||||
TMEM195 Blocking Peptide - 33R-9719 from Fitzgerald
|
||||||||||
TMEM195 fusion protein - Ag15774 from Proteintech Group
|
||||||||||
TMEM195 fusion protein - ag15580 from Proteintech Group
|
||||||||||
Recombinant Human TMEM195, His-tagged - TMEM195-3284H from Creative Biomart
|
||||||||||
FLJ16237 Protein Lysate - orb333602 from Biorbyt
|
||||||||||
AGMO Recombinant Protein Antigen - NBP1-83674PEP from Novus Biologicals
|
||||||||||